Tumour lysis syndrome: new territory for a familiar foe?
Circulating proplatelets in a patient with acute blood loss following liver transplantation
Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia
Management and controversies of classical Hodgkin lymphoma in pregnancy
Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches
Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents
Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach
A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations
The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma
Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning
Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease
Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation
Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience
Subcutaneous bortezomib combined with weekly cyclophosphamide and dexamethasone is an efficient and well tolerated regime in newly diagnosed multiple myeloma
Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia
Managing children with chronic myeloid leukaemia
Managing children with chronic myeloid leukaemia – response to baccarani